Alastair has 30+ years of experience in the biopharmaceutical development of pre and post approval drugs.
From 2001-2017, Alastair held a variety of senior positions at AstraZeneca, including as Global Head of Delivery for RWE. Here, he had responsibility for the delivery of both pre and post approval evidence generation programs supporting key assets that have gone on to become world-class products.
From 2017-2024, he worked at Syneos Health, a world-leading Product Development Organisation. As a Senior Vice President of Strategic Alliances, he assisted key clients to clinically develop and successfully commercialise assets, particularly through the generation of RWE.
Now Vice President, Medical Affairs at Sciensus, Alastair successfully helps patients across Europe gain access to treatments and candidate drugs. Enabled by this primary source patient access, data is captured through an innovative digital platform. These real-world insights drive better health outcomes including adherence and patient engagement.